(en)TOPICAL DERMATOLOGICAL COMPOSITIONS CONTAINING FROM 0.1 TO 10% BY WEIGHT OF A HIGHER ALKYL ESTER OF 5-PYRROLIDONE-(2)-CARBOXYLIC ACID OF THE FORMULA 2-(RO-CO-)-5-PYRROLIDONE ((NC-),R1-PHENYL)-O-CH2-CH(-OH)-CH2-NH-C(-CH3)<(-(CH2)N-) WHEREIN R IS STRAIGHT OR BRANCHED ALKYL OF 8-30 CARBON ATOMS.

1.ApplicationNumber: US-21729072-A
1.PublishNumber: US-3836665-A
2.Date Publish: 19740917
3.Inventor: EBERHARDT H,DT
SCHAEFER H,DT

4.Inventor Harmonized: EBERHARDT H()
SCHAEFER H()

5.Country: US
6.Claims:
(en)TOPICAL DERMATOLOGICAL COMPOSITIONS CONTAINING FROM 0.1 TO 10% BY WEIGHT OF A HIGHER ALKYL ESTER OF 5-PYRROLIDONE-(2)-CARBOXYLIC ACID OF THE FORMULA 2-(RO-CO-)-5-PYRROLIDONE ((NC-),R1-PHENYL)-O-CH2-CH(-OH)-CH2-NH-C(-CH3)<(-(CH2)N-) WHEREIN R IS STRAIGHT OR BRANCHED ALKYL OF 8-30 CARBON ATOMS.

7.Description:
(en)United States Patent US. Cl. 424-274 4 Claims ABSTRACT OF THE DISCLOSURE Topical dermatological compositions containing from 0.1 to by weight of a higher alkyl ester of 5-pyrrolidone-(2)-carboxylic acid of the formula I COOR H wherein R is straight or branched alkyl of 8-30 carbon atoms.
This invention relates to novel topical dermatological compositions containing. certain higher alkyl esters of 5-pyrrolidone-(2)-carboxylic acid, as well as to therapeutic and cosmetic methods forthe treatment and care of the human skin.
The Prior Art Published Netherlands application No. 65/04878 [see Chem; Abstr. 64, 9686 1966)] discloses, inter alia, the octyl and octadecyl esters of S-pyrrolidone-Z-carboxylic acid and their use as starting materials for the preparation of certain polymers and copolymers.
The Invention We have discovered that higher alkyl esters of S-pyrrolidone-(2)-carboxylic acid of the formula Method A By esterifying S-pyrrolidone-(2)-carboxylic acid or a reactive derivative thereof, such as a halide or anhydride, with ahigher alkanol of the formula HOR wherein R has the same meanings as in formula I.
The esterification reaction is preferably performed in an inert solvent medium, such as benzene, toluene or chloroform, and in the presence bf a5 strong acid, such as hydrochloric acid or sulfuricacid, or in the presence of an acid-activating agent, such as thionyl chloride or N,N' dicyclohexyl-carbodiimide, at a temperature up to and including the inert solvent medium. If the alkanol of theformulalIis provided in sufficient excess over the amount necessary for esterification of the S- yrrolidone- 3,836,665 Patented Sept. 17, 1974 (2)-carboxylic acid, it may also serve as the solvent medium for the reaction.
However, the esterification reaction may also be performed in a vessel provided with a water separator in the presence of an acid, such as sulfuric acid or p-toluenesulfonic acid, or with a reactive derivative of S-pyrrolidone- (2)-carboxylic acid.
Method B By intramolecular cyclization of a compound of the formula N Hz (III) wherein R has the same meanings as in formula I, and X is hydroxyl, halogen or lower alkoxy,
at elevated temperatures in the presence of an alkanol of the formula II.
The cyclization reaction is preferably performed in the molten state without a solvent medium or in the presence of a solvent medium, such as an excess of the alkanol of the formula II, and optionally in the presence of an acid, such as hydrogen chloride or sulfuric acid, at elevated temperatures up to 250 C. The reaction may, however, also be performed in the presence of an acid-activating agent, such as thionyl chloride or N,N-dicyclohexylcarbodiimide.
The following examples illustrate the preparation of higher alkyl 5-pyrrolidone-(2)-carboxylates of the formula I.
EXAMPLE 1 5-Pyrr0lid0ne-(2)-carb0xylic acid hexadecyl ester by method B A mixture consisting of 300 gm. (2 mols) of glutamic and 800. gm. (3.3 mols) of cetyl alcohol was heated to C., and, while maintaining-this temperature and stirring, gaseous hydrogen chloride was introduced into the molten mixture for 15 hours. Thereafter, the reaction mixture was allowed to cool, was then dissolved in chloroform, and the resulting solution was filtered. The filtrate was concentrated by evaporation in vacuo, the concentrate was fractionally distilled in a high vacuum, and the fraction passing over between 220 and 230 C. at 0.1 mm. Hg was recrystallized from methanol and petroleum ether, yielding 150 gm. of the compound of the formula 180 ml. of thionyl chloride were added dropwise to a solution of 200 gm. (1.55 mols) of 5-pyrrolidone-(2)- carboxylic acid in 500 m1. of absolute chloroform, and
the resulting mixture was stirred for 316 hours at room temperature. Subsequently, 200 ml. of absolute chloro form were added to the reaction mixture, and the precipitated 5-pyrrolidone-(2)-carboxylic acid chloride was collected by vacuum filtration. The filter cake was suspended in Zliters of a mixture consisting of absolute chloroform and ether (2:1), 380 gm. of cetyl alcohol were slowly added to the suspension, and the resulting mixture was first stirred for three hours at room temperature and then refluxed for two hours. After cooling, the chloroform was evaporated in vacuo, the residue was again taken up in chloroform, the resulting solution was filtered, the chloroform was again evaporated in vacuo, and the residue Was fractionally distilled in a high vacuum. The fraction passing over between 224 and 228 C. at 0.08 mm. Hg was recrystallized from methanol and petroleum ether, yielding 246 gm. of hexadecyl S-pyrrolidone-(Z)-carboxylate having a melting point of 72-73 C.
EXAMPLE 3 Hexadecyl S-pyrrolidone-(Z)-carbxylate by method A A mixture consisting of 36 gm. (0.28 mol) of -pyrrolidone-(2)-carboxylic acid, 74.2 gm. (0.30 mol) of cetyl alcohol, 250 ml. of toluene and 4.5 ml. of concentrated sulfuric acid was heated at its boiling point for seven hours in a vessel provided with a water separator. Thereafter, the reaction solution was allowed to cool, the toluene was evaporated in vacuo, the residue was taken up in 1 liter of chloroform, and the resulting solution was washed with water until neutral. The chloroform phase was then worked up as described in the preceding example, yielding 30 gm. of hexadecyl 5-pyrrolidone-(2)- carboxylate having a melting point of 73 C.
EXAMPLE 5 Using a procedure analogous to that described in Example 2, nonyl S-pwrrolia'one-(Z)-carb0xylate, b.p. loo-169 C. at 0.2 mm. Hg, was prepared from S-pyrrolidone(2)-carboxylic acid chloride and n-nonyl alcohol.
EXAMPLE 6 Using a procedure analogous to that described in Example 2, decyl S-pyrrolidone-(Z)-carb0ocylate, m.p. 48 C., was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and l-decanol.
EXAMPLE 7 Using a procedure analogous to that described in Example 2, undecyl S-pyrrolia'one-(2)-carboxylate, m.p. 38 C., was prepared from S-pyrrolidone-(2)-carboxylic acid chloride and n-undecyl alcohol.
EXAMPLE 8 Using a procedure analogous to that described in Example 2, dodecyl S-pyrrolidone-(Z)-carb0xyla1e, m.p. 6466 C., was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and l-dodecanol.
EXAMPLE 9 Using a procedure analogous to that described in EX- ample 2, tridecyl S-pyrrolidone-(Z)-carboxylate, m.p. 50-5 1 C., was prepared from 5-pyrrolidone (2)-carboxylic acid chloride and l-tridecanol.
EXAMPIJE 10 Using a procedure analogous to that described in Example 2, tetradecyl S-pyrrolidone-(Z)-carb0xylate, m.p.
67 C., was prepared from S-pyrrolidone-(Z)-carboxylic acid chloride and n-tetradecyl alcohol.
' EXAMPLE 11 Using a procedure analogous to that described in Example 2, Z-hexadecyl S-pyrrolidone-(Z)-carboxylate, m.p. 56-57" C., of the formula was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and 2-hexadecanol.
EXAMPLE 13 Using a procedure analogous to that described in Example 2, 3-hexadecyl S-pyrrolidone-(2)-carboxylate, m.p. 63-64 C., of the formula was prepared from S-pyrrolidone-K2)-carboxylic acid chloride and 3-hexadecanol.
EXAMPLE .14
EXAMPLE 15 Using a procedure analogous to that described in Example 2, 9-heptadecyl S-pyrrolidone-(Z)-carlb0xylate, m.p. 59-60" C., was prepared from 5-pyrrolidone-(2)- carboxylic acid chloride and 9-heptadecanol.
EXAMPLE 16 Using a procedure analogous to that described in Example 2, octadecyl 5-pyrrolidone-(2)-carboocylate, m.p. 78 C., was prepared from S-pyrrolidone-(2)-carboxylic acid chloride and l-octadecanol.
EXAMPLE 17 Using a procedure analogous to that described in Example 2, 3-0ctadecyl 5-pyrrolidone-(2)-carb0xylate, m.p. 65-66 C., was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and 3-octadecanol.
EXAMPLE 18 Using a procedure analogous to that described in Example 2, nonadecyl S-pyrrOIidone-(Z)-carb0xylate, m.p. 67-69 C., was prepared from 5-pyrr0lid0ne-(2)-carboxylic acid chloride and l-nonadecanol.
EXAMPLE I 19 Using a procedure analogous to that described in Example 2, eicosyl S-pyrrolidone-(Z)-carboxylate, m.p. 70-72 C., of the formula was prepared from 5-pyrr0lidone-(2) carboxylic acid chloride and eicosanol. I a
5. EXAMPLE 20 Using a procedure analogous to that described in Example 2, 2-octyl-dodecyl S-pyrrolidone-(Z)-carboxylate, b.p. 214-217 C. at 0.5 mm. Hg, of the formula was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and 2-octyl-l-dodecanol.
EXAMPLE 21 Using a procedure analogous to that described in EX- ample 2, docosyl S-pyrrolidone-(Z)-carbvcylate, m.p. 7475 C., was prepared from -pyrrolidone-(2)-carboxylic acid chloride and n-docosanol.
EXAMPLE 22 Using a procedure analogous to that described in Example 2, Z-heptadecyl 5-pyrr0lidone-(2)-carboxylwte, m.p. 65 C., was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and Z-heptadecanol.
EXAMPLE 23 Using a, procedure analogous to that described in Example 2, 'tetracosyl S-pyrrolidone-(2)-carb0xylate, mp. 82-83" C., was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and l-tetracosanol.
The ester had a thin-layer chromatographic R -value of 0.35 (silicagel plate; system: Benzene/acetone=60/ 40).
EXAMPLE 25 Using a procedure analogous to that described in Example 2, lzexacosyl 5-pyrr0lid0ne-(2)-carb0xylate, rn.p. 80:82 C., was prepared from 5-pyrrolidone-(2)-carboxylic acid chloride and l-hexacosanol.
The ester had a thin-layer chromatographic R -value of 0.35 *(silicagel plate; system: Benzene/acetone: 60/40).
, As indicated above, we have discovered that the compounds embraced by formula I above possess therapeutic and cosmetic properties which make them useful as active ingredients in conventional topical dermatological compositions, such as ointments, creams, aerosols, powders,;tinctures, gels, pastes, essences and lotions intended f r the cosmetic care and therapeutic treatment of the human skin. More particularly, the compounds of the formula I exhibit sebaceous gland excretion-inhibiting, antiphlogistic, capillary-stabilizing, skin-softening and skin moisture-increasing activities. Particularly effective are those compounds of the formula I wherein R is alkyl of 16 to 20 carbon atoms.
The sebaceous gland excretion-inhibiting activity was ascertained by the glass block 'method described by Sc' haefer and Kuhn-Bussius in Arch- Klin. exper. Derrn. 238, 429435 (1970). Small glass blocks, the facets of which have been roughened or frosted, are pressed against the skin surface where the amount of skin fat is measured. The skin fat or sebum transferred fro'm'the skin to the glass facet makes-the blocks more translucent, and the increase in translucence is directly proportional to the amount of sebum present on the skin area. The tr-anslucence is measured in a photometer. Prior to measurement of the degree of re-fatting of the skin, the skin fat was removed with a plastic foil.
0.25 'ml. of an ethanolic 5% solution of the compound to be tested was applied to half of the forehead of 5 to 10 human test subjects, while 0.25 ml. of ethanol was applied to half of the forehead of a group of 5 to 10 control subjects. After minutes the skin fat was removed with the plastic foil, and after three additional hours the degree of re-fatting was determined with the aid of the small glass blocks referred to above. The following results were obtained:
Average extinction values Controls Treated Difference 5-pyrrolidone-(2)carboxylate The antiphlogistic activity of the compounds of the present invention was ascertained by the dinitrochlorobenzene-eczema method [see A. 1. Scott, Brit. J. Dermatol. 77, 586 (1965)].
The compound to be tested was applied in the form of an ethanolic 5% solution to the shaved flanks of a group of 10 guinea pigs which had been sensitized with dinitrochlorobenzene. An analogous control group was treated with only ethanol. The treatment was effected 30 minutes prior to release of the allergic reaction with a 1%0 solution of dinitrochlorobenzene in acetone. The results were visually evaluated 22 hours thereafter. The following results were obtained.
5-Pyrrolidone-( 2 The capillary-stabilizing activity of the compounds of the formula I was ascertained by the Evans Blue method [see LR. P arrat et al.. J. Physiol. 140, 1958)].
An ethanolic 5% solution of the compound to be tested was applied with an :artists brush to one side of the shaved abdominal skin surface of a group of 6 to 12 adult laboratory rats under pentobarbital sodium anesthesia, and on the other side only ethanol was applied in the same manner. ()ne hour later, the test animals were administered an intravenous injection of Evans Blue, and five minutes thereafter an inflammation was induced on the treated abdominal skin areas by dropping one drop of an ethanolic 10% perchloroethylene solution thereon. After an interval of 15 minutes a reading of the degree of blue coloration was made on both sides of the abdomen on which two test patches each were made. The following results were obtained:
5-Pyrrolidone-(2)- Inhibition of blue coloration carboxylate in percent Dodecyl 69 Tetradecyl -s 65 Hexadecyl 75 Q-Heptadecyl 78 The acute intraperitone'al toxicity of the compounds of the formula I was determined in mice by conventional methods. Hexadecyl 5-pyrrolidone-(2)-carboxylate was found to havev an LD of 1950 mgm./kg. i.p., and the other S-PYrrolidone-(Z)-carboxyl-ates were found to have an LD of greater than 1000 mgm./-kg. i.p., although the exact values were not determined.
For cosmetic and/or therapeutic treatment of the human skin the compounds embraced by formula I are incorporated in conventional manner into conventional forms of topical dermatological compositions at a concentration of 0.1 to 10%, preferably 0.5 to by weight based on the total weight of the composition. Such conventinal forms of topical compositions include ointments, creams, aerosols, powders, tinctures, gels, pastes and lotions intended for use in the care and treatment of the skin, and such compositions may, in addition. contain one or more other active ingredients, such as vitamins, corticosteroids, steroids, antihistamines, keratolytics, antibiotics or disinfectants.
The following examples illustrate a few topical compositions for the cosmetic and/or therapeutic treatment of the skin, which comprise a compound of the formula I. The parts are parts by weight unless otherwise specified.
EXAMPLE 26 Cream The cream composition is compounded from the following ingredients:
'Parts' Hexadecyl S-pyrrolidone-(2)-carboxylate 3.0 Benzalkonium chloride 0.1 Cremophor 0 1 4.0 Glycerin monostearate 4.0 Lanette O 5.0
Spermaceti 3.0 Cetiol V 10.0
Distilled water Q.s. ad 100.0
Long-chain, high-molecular, water-soluble, Wax-like polyglycolether: a commercial cosmetic and pharmaceutical emulsifier for high-molecular alcohols, fatty acids, waxes, Wool grease, spermaceti, etc.
-Mixture of cetyl and stearyl alcohols; a commercial neutral, skin-compatible, consistancy-lmparting factor for ointments, creams and emulsions.
Mixture of esters of unsaturated fatty acids, mainly oleyl oleate; a commercial, conventional. skin-penetrating lowviscosity liquid additive for cosmetic creams and the like.
Preparation The benz-alkonium chloride is dissolved in the distilled water at 70 C. (I). The pyrrolidone-carboxylate is homogeneously suspended in the molten (70 C.) mixture of the Cremophor, the glycerin monostearate, the Lanette, the sperm-aceti :and the Cetiol (II). Suspension II is emulsified at 70 C. into solution I, and the composition is stirred until cool.
EXAMPLE 27 Ointment The ointment is compounded from the following ingredients:
Parts Hexadecyl S-pyrrolidone-(2)-carboxylate 3.0 Cremophor O 6.0 Cremophor A solid 1 1.0 Wool grease 2.0
P araflin oil 45.0 Vaseline Q.s. ad 100.0
1 Non-ionic derivative of fatty substance with polyethyleneoxide radical; a commercial Water-dispersible emulsifier for paraifin oil, Vaseline and vegetable oils.
Preparation The Cremophors, the wool grease, the paraflin oil and the Vaseline are admixed with each other. the mixture is melted by heating to 70 C., the pyrrolidone-carboxylate is suspended in the molten mixture, and the composition is stirred until cool.
Isopropanol- 30.0
Distilled water Q.s. ad 100.0
carboxypolyrnethylene; carboxyvinyl polymer with very high molecular weight; form colloidal solutions with water;
a commercial thickening agent for cosmetics.
A viscous oil similar in composition to Cremophor 0 and A; a commercial emulsifier for cosmetics.
Preparation The pyrrolidone-carboxylate, the Cremophor and the triethano'lamine are dissolved in the isopropanol, and the resulting solution is stirred into the solution of the carbopol in the distilled water. I
EXAMPLE 29 Bath oil The composition is compounded from the following ingredients:
Parts Hexadecyl S-pyrrolidone-(2)-carboxylate 5.0 Tex apon N 25 30.0 Comperlan OD 5.0 Isopropanol 20.0 Ethereal Oil 2.0
Distilled water Q.s. ad 100.0
Fatty alcohol ether sulfate; 11 commercial washing, wetting and dispersing agent.
2 A fatty acid alkyloiamide; commercial consistency-impartlug factor for cosmetic and pharmaceutical preparations.
Prep anation The pyrrolidone-carboxylate and the ethereal oil are dissolved in the isopropanol, and the resulting solution is stirred into the solution of the Tex'apon and the Comperlan in the distilled water.
EXAMPLE 30 Hair tonic The composition is compounded from the following ingredients:
. Parts Hexadecyl 5-pyrrolidone-(2)-c-arboxylate 0.5 Diisopropyl adipate ..1 0.2 Perfume oil 0.1 Isopropanol 50.0
Distilled water Q.s. ad 100.0
Preparation The pyrrolidone-carboxylate, the isoadipate and the perfume oil :are dissolved in the isopropanol, and the resulting solution is admixed with the distilled water by stirring.
EXAMPLE 31 Aerosol dry spray The spray is compounded from the. following ingredients:
. 1 Parts Hexadecyl 5-pyrrolidone- (2) carboxylate 3.0 Span '85 0.4 Frigen 11 A 3.0
Frigen 12/114 (40:60). ,.93.6
' Preparation The pyrrolidone-carboxylate, the Span and the Frigen 11 are intimately admixed in a ballmill, the. mixture is "9' cooled to -15 C., and slowly introduced into the Frigen 12/ 11,4 mixture at 40 to 50 C., and the composition is filled into aerosol containers, accompanied by stirring.
EXAMPLE 32 Aerosol foam The foam composition is compounded from the following ingredients:
The pyrrolidone-c-arboxylate is dissolved in the ethanol (solution I). The Cremophor, the Tween and the Texapon are dissolved in the distilled water (solution II). Solution I is stirred into solution II, and the resulting concentrate is filled into aerosol cans. After the valve has been aflixed to the filled cans, the propellant gas mixture is introduced under pressure.
-EXAMPLE 33 Cream Thecomposition iscompounded from the following ingredients:
I-Iex ad ecyl -pyrrolidone-(2)-c rboxylate parts 3.0 Benzalkon A do 0.1 Cremophor 0 do 4.0 Glycerin monostearate do 4.0 Lanette O asdo 5.0 Spermaceti do 3.0 Cetiol V do 10.0 Vitamin A acetate I.U 30,000 Vitamin E acetate I.U 20
Distilled water .s. ad, parts 1"00.0
The composition is compounded in a manner analogous to that described in Example 26.
EXAMPLE 34 Lotion The lotion is compounded from the following ingreclients:
Parts Hexadecyl S-pyrrolidone-(Z)-carboxylate 3.0 Span 40 1.0 Cremophor O 2.0 Lanette O 2.0 Spermacetic 1.0 Cetiol V 5.0 Paraffin oil, soluble 1.0- Methylparaben 0.1
Distilled water Q.s. ad 100.0
Preparation The Span, the Cremophor, the Lanette, the spermaceti, the Cetoil and the parafiin oil are admixed with each other, the mixture is melted at 70 C., and the pyrrolidone-carboxylate is dissolved in the molten mixture. The distilled water is heated to 80 C., the methylparaben is dissolved therein, the resulting solution is cooled to 70 C. and added to the molten fatty mixture, and the composition is homogenized and stirred until cool.
10 EXAMPLE 3s Shampoo The shampoo is compounded from the following ingreclients:
Parts Hexadecyl S-pyrrolidone-(Z)-carboxylate 3.0 Texapon N 25 48.0 Comperlan O D 7.0 Methyl cellulose 1.0 Perfume oil 0.2 Methylparaben 0.5
Distilled water Q.s. ad 100.0
Preparation The distilled water is heated to C., the methylparaben is dissolved therein, and the methyl cellulose is suspended in the aqueous solution. The Zetesol and the perfume oil are admixed with each other, the pyrrolidonecarboxylate is dispersed in the mixture with a high-speed stirrer, the dispersion is added to the methyl cellulose slurry, and the resulting composition is homogenized and purged of air.
EXAMPLE 36 Powder The powder is compounded from the following ingredients:
Parts Hexadecyl 5-pyrrolidone-(2)-carboxylate 3.0 Colloidal silicic acid 1.0 Magnesium stearate 0.2
AMN corn starch Q.s. ad 100.0
Preparation The pyrrolidone-carboxylate, the colloidal silicic acid and the magnesium stearate are successively added to about one-third of the indicated amount of the corn starch, the mixture is thoroughly blended, the remaining amount of corn starch is added thereto, and the resulting composition is again thoroughly blended.
EXAMPLE 37 Paste The paste is compounded from the following ingreclients:
Parts Hexadecyl 5-pyrrolidone-(2)-carboxylate 3.0 Lanogen 1500 1 20.0 lsopropanol 45.0 Veegum 2 pharm. 10.0 Pigment+ dye 1.0 Perfume oil 0.2
Distilled water Q.s. ad 100.0
1 111 commercial ointment base made from polyethyleneg yco Flocculated colloidal magnesium aluminum silicate; a commercial emulsifying, suspending and thickening agent.
Preparation The pyrrolidone-carboxylate is dissolved in the ointment base at 60 C. (solution I). The perfume oil is dissolved in the isopropanol (solution II). The distilled water is heated to 60 C., the Veegum is dispersed therein and allowed to swell, solutions I and II and the pigment and dye are added thereto, and the composition is thoroughly kneaded and homogenized.
1 1 EXAMPLE 3s Tincture The tincture is compounded from the following ingredients:
Parts Hexadecyl 5-pyrrolidone-(2)-carboxylate 3.0 Isopropanol 25.0 Ethanol (96%), pure 25.0 Perfume oil 0.2
Distilled water Q.s. ad 100.0
Preparation The isopropanol is admixed with the ethanol, the mixture is heated to 60 C., the pyrrolidone-carboxylate and the perfume oil are dissolved therein, the distilled water is added to the solution, and the resulting aqueous mixture is cooled to room temperature and filtered.
EXAMPLE 39 Gel with antibiotic The gel is compounded from the following ingredients:
Distilled water Q.s. ad 100.0
1 Organic derivatives of hydrous magnesium aluminum silicate minerals; a commercial gelling agent for viscosity and flow control.
Preparation The Bentone is stirred with a high-speed stirrer into about two-thirds of the required amount of distilled water and allowed to swell therein (I). The salicylic acid and the triethanolamine are dissolved in the remainder of the water (II). The pyrrolidone-carboxylate and the antibiotic is dissolved in the isopropanol (III). II and III are added to I while stirring, and the resulting composition is homogenized and purged of air.
While the above composition examples illustrate only the hexadecyl ester of 5-pyrrolidone-(2)-carboxylic acid as an active ingredient, it should be understood that any of the other compounds embraced by formula I may be substituted therefor in Examples 26 through 39.
Likewise, the amount of active ingredient in these illustrative examples may be varied to achieve the concentration range set forth above, and the amounts and nature of the inert carrier ingredients may be varied to meet particular requirements.
While the present invention has been illustrated with the aid of certain specific embodiments thereof, it will be readily apparent to others skilled in the art that the invention is not limited to these particular embodiments, and that various changes and modifications may be made without departing from the spirit of the invention or the scope of the appended claims.
We claim:
1. A topical dermatological composition for cosmetic sebaceous gland excretion-inhibiting treatment or therapeutic antiphlogistic treatment of the skin, consisting essentially of an inert dermatological carrier and from 0.1 to 10% by weight, based on total weight of the composition, of a compound of the formula O i oooR References Cited UNITED STATES PATENTS 2/ 1966 Laden 424- -74 OTHER REFERENCES Chemical Abstracts, Vol. 64 (1966), 9686-9687.
ALBERT T. MEYERS, Primary Examiner F. E. WADDELL, Assistant Examiner US. 01. X.R. 424-45, 46, 47, 365